MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 110 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $157,289 | +35.0% | 14,470 | 0.0% | 0.00% | – |
| Q3 2023 | $116,484 | -24.2% | 14,470 | +2.3% | 0.00% | – |
| Q2 2023 | $153,669 | +3.8% | 14,150 | -10.8% | 0.00% | – |
| Q1 2022 | $148,000 | -21.3% | 15,864 | 0.0% | 0.00% | – |
| Q4 2021 | $188,000 | +5.0% | 15,864 | +1.0% | 0.00% | – |
| Q3 2021 | $179,000 | -36.5% | 15,713 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $282,000 | – | 15,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,156,803 | $15,279,000 | 3.01% |
| Lion Point Capital, LP | 3,684,622 | $18,959,000 | 2.16% |
| Bleichroeder LP | 1,322,463 | $6,401,000 | 1.32% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $6,926,000 | 0.81% |
| 683 Capital Management, LLC | 1,900,000 | $9,196,000 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,510,831 | $16,992,000 | 0.65% |
| Granite Point Capital Management, L.P. | 472,056 | $2,285,000 | 0.58% |
| Stonepine Capital Management, LLC | 242,327 | $1,173,000 | 0.55% |
| Avoro Capital Advisors LLC | 3,150,000 | $15,246,000 | 0.30% |
| Artal Group S.A. | 1,000,000 | $4,840,000 | 0.26% |